GLENMERE PHARMS Trademark
Trademark Overview
On Wednesday, January 14, 2026, a trademark application was filed for GLENMERE PHARMS with the United States Patent and Trademark Office. The USPTO has given the GLENMERE PHARMS trademark a serial number of 99593827. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 9, 2026. The GLENMERE PHARMS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and medicinal preparations for human and veterinary use for the management of inflammation and inflammation-related pain, swelling, and tissue irritation; Pharmaceutical and medicinal preparations for human and veterinary use for pain management; Pharmaceutical and medicinal preparations for human and veterinary use for musculoskeletal pain, joint pain, and muscle pain; Pharmaceutical and medicinal preparations for human and veterinary use for wound healing and wound pain management; Pharmaceutical and medicinal preparations for human and veterinary use for the management of symptoms and complications associated with diabetes, namely, inflammation, neuropathic pain, tissue irritation, and impaired wound healing
General Information
| Serial Number | 99593827 |
| Word Mark | GLENMERE PHARMS |
| Filing Date | Wednesday, January 14, 2026 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 9, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical and medicinal preparations for human and veterinary use for the management of inflammation and inflammation-related pain, swelling, and tissue irritation; Pharmaceutical and medicinal preparations for human and veterinary use for pain management; Pharmaceutical and medicinal preparations for human and veterinary use for musculoskeletal pain, joint pain, and muscle pain; Pharmaceutical and medicinal preparations for human and veterinary use for wound healing and wound pain management; Pharmaceutical and medicinal preparations for human and veterinary use for the management of symptoms and complications associated with diabetes, namely, inflammation, neuropathic pain, tissue irritation, and impaired wound healing |
| NOT AVAILABLE | "PHARMS" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 14, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOT AVAILABLE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 01 - Individual |
| Address | Chester, NY 10918
US |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Chester, NY 10918
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, January 14, 2026 | NEW APPLICATION ENTERED |
| Wednesday, January 14, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 14, 2026 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, May 12, 2026 | ASSIGNED TO EXAMINER |
| Thursday, May 14, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 14, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 14, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 14, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, May 14, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 14, 2026 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Thursday, May 14, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 14, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 14, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 14, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, May 14, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 3, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 9, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 9, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
